Drug intelligence / Profile preview

S-sulphocysteine

Development stage
Discontinued
Lead developer
Origin Biosciences
Modality
Small Molecules
01

Overview

S-sulphocysteine is a naturally occurring, endogenous amino acid derivative formed when sulfur metabolism is disrupted, such as in molybdenum cofactor deficiency or sulfite oxidase deficiency. It belongs to the class of organic compounds known as s-conjugated L-cysteines, where the sulfur atom of L-cysteine is substituted with a sulfo group. Structurally, it is a thiosulfate and an analog of glutamate. Mechanistically, S-sulphocysteine acts as a potent agonist at N-methyl-D-aspartate (NMDA) receptors in the central nervous system, leading to increased calcium influx and downstream excitotoxic signaling that can result in neurotoxicity and neuronal damage. Elevated levels are diagnostic markers for certain metabolic disorders affecting sulfur metabolism[5][6]. It has no approved pharmaceutical use but plays an important role as a biomarker and mediator of toxicity in rare genetic diseases.

Other names
L-cysteine S-sulfateS-sulfo-L-cysteinecysteine-S-sulfatecysteine-S-sulfonatecysteinyl-S-sulfonatecysteinyl-S-sulfonic acidS-sulpho-L-cysteinealaninethiosulfuric acid
02

Targets

AMPAR (AMPA receptor)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on S-sulphocysteine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S-sulphocysteine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call